1 Compelling Reason to Invest in Eli Lilly Stock Immediately
In September, Lilly achieved another significant milestone by securing FDA approval for Ebglyss, an injectable treatment for moderate-to-severe eczema.
In September, Lilly achieved another significant milestone by securing FDA approval for Ebglyss, an injectable treatment for moderate-to-severe eczema.
MatteRock EA is a smart trading robot with grid, hedging, and partial loss closing features. Designed for experienced traders to manage risk and recover losing positions efficiently.
Advanced Micro Devices (AMD) is showing a strong reversal from the lower trendline of its long-term ascending channel. Bullish structure remains intact, offering strong upside potential—exclusive insight for paying members.
American Express (AXP) shows strong bullish momentum in a rising channel with ~13% upside potential. Dividend yield of 1.21% offers steady income even if markets decline—making it a reliable long-term holding.